产品目录
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 181121 | AZD-5904 | 618913-30-7 | ≧98.0% |  |
| AZD5904是一个有效的口服生物利用率MPO抑制剂。在临床前研究中,AZ | ||||
| 171454 | 1-(4-溴-6-甲基吡啶-2-基)乙-1-酮 | 1060810-24-3 | ≧98.0% | ethan-1-one_1060810-24-3.png) |
| 1-(4-溴-6-甲基吡啶-2-基)乙-1-酮, CAS 1060810-24-3. | ||||
| 20471 | FHD-286 | 2671128-05-3 | ≧98.0% |  |
| FHD-286 is an oral, small-molecule, selective, allosteric inhibitor of BRG1 and BRM i | ||||
| 184163 | 2-amino-3-methoxy-4-(3-morpholin-4-ylpropoxy)benzonitrile | 1032570-98-1 | >96% |  |
| 2-amino-3-methoxy-4-(3-morpholin-4-ylpropoxy)benzonitrile是一种药物中间体。 | ||||
| 20657 | Zilurgisertib | 2173389-57-4 | ≧98.0% |  |
| Zilurgisertib（之前称为 INCB 00928）是一种激活素受体样激酶 2（ALK2， | ||||
| 237071 | Flavopiridol ( 夫拉平度 ) | 146426-40-6 | ≧98.0% |  |
| Alvocidib is a synthetic dihydroxyflavone that is 5,7-dihydroxyflavone which is subst | ||||
| 20266 | Linzagolix | 935283-04-8 | ≧98.0% |  |
| Linzagolix 是一种新型的口服 GnRH 受体拮抗剂，可有效治疗子宫内膜 | ||||
| 20510 | CC-92480 ( Mezigdomide ) | 2259648-80-9 | ≧98.0% |  |
| CC-92480 是一种有效的新型 CELMoD 化合物，旨在快速最大程度地降解 | ||||
| 20549 | STC-15 | 2648257-56-9 | ≧98.0% |  |
| STC-15 is a first-in-class inhibitor of RNA modification and is the first ever RNA me | ||||
| 51802 | TIC10 ( ONC201 ) | 1616632-77-9 | 99.85% | _1616632-77-9.png) |
| ONC201 / TIC10是人类TRAIL基因的新型小分子诱导剂，可改善重组TRAIL的 | ||||
| 23122601 | Navacaprant | 2244614-14-8 | ≧98.0% | _2244614-14-8.png) |
| Navacaprant (NMRA-335140, BTRX-140) 是一种口服、选择性、可逆的 kappa 阿 | ||||
| 20509 | GLPG3667 | 2308520-97-8 | ≧98.0% |  |
| GLPG3667 是一种口服强效选择性小分子 TYK2 抑制剂，正在开发用于治 | ||||